Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)Metastatic Pancreatic Ductal AdenocarcinomaRecruitingPhase 22025-02-06NCT05472259

2 results · Page 1 of 1

Swipe the table sideways for more columns.

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AZ ImeldaBonheidenBelgium2
AZ Maria MiddelaresGhentBelgium14
AZ St-LucasBrugesBelgium1
AZ TurnhoutTurnhoutBelgium8
CHC MontLégiaLiègeBelgium3
CHR NamurNamurBelgium1
CHU Ambroise ParéMonsBelgium3
Cliniques Universitaires Saint-Luc UCLBrusselsBelgium1
Grand Hopital de CharleroiCharleroiBelgium1
Pôle Hospitalier Jolimont (HELORA)Haine-Saint-PaulBelgium1
ULB ErasmeBrusselsBelgium1
University Hospital GhentGhentBelgium6
UZ AntwerpenAntwerpBelgium1